New insider Tom Penny claimed ownership of 33,857 shares (SEC Form 3)
$EQ
Biotechnology: Pharmaceutical Preparations
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 03/06/2024 |
3. Issuer Name and Ticker or Trading Symbol
Equillium, Inc. [ EQ ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 33,857 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Option (right to buy) | (1) | 01/30/2029 | Common Stock | 65,000 | $2.45(2) | D | |
| Employee Stock Option (right to buy) | (1) | 12/09/2029 | Common Stock | 45,000 | $2.45(2) | D | |
| Employee Stock Option (right to buy) | (1) | 01/03/2031 | Common Stock | 40,000 | $5.03(2) | D | |
| Employee Stock Option (right to buy) | (1) | 01/18/2032 | Common Stock | 60,000 | $3.86(2) | D | |
| Employee Stock Option (right to buy) | (1) | 05/01/2032 | Common Stock | 40,000 | $2.52(2) | D | |
| Employee Stock Option (right to buy) | (1) | 01/02/2033 | Common Stock | 100,000 | $1.06(2) | D | |
| Employee Stock Option (right to buy) | (1) | 01/01/2034 | Common Stock | 100,000 | $0.73 | D | |
| Explanation of Responses: |
| 1. Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. |
| 2. Effective as of August 14, 2023, the Company's board of directors approved the repricing of the options to an exercise price of $0.785 per share. However, if a repriced option is exercised prior to the Retention Period End Date (as defined in Item 5 of the Company's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023, filed with the SEC on August 9, 2023), or the optionholder's employment or service terminates under certain circumstances prior to the Retention Period End Date, the optionholder will be required to pay a premium price equivalent to the original exercise price per share of the repriced options. Such original exercise price per share is reflected in this column. |
| /s/ Penny Tom | 03/06/2024 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||